Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy)

Background: Pharmacological treatment of benign prostatic hyperplasia (BPH)/benign prostatic obstruction (BPO)-associated lower urinary tract symptoms (LUTS) aims at improving patients’ quality of life by managing urinary symptoms and preventing complications and disease progression. However, contin...

Descripción completa

Detalles Bibliográficos
Autores principales: Armando, Lucrezia Greta, Baroetto Parisi, Raffaella, Remani, Elisa, Esiliato, Mariangela, Rolando, Cristina, Vinciguerra, Valeria, Diarassouba, Abdoulaye, Cena, Clara, Miglio, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778582/
https://www.ncbi.nlm.nih.gov/pubmed/36554090
http://dx.doi.org/10.3390/healthcare10122567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778582/
https://www.ncbi.nlm.nih.gov/pubmed/36554090
http://dx.doi.org/10.3390/healthcare10122567

Ejemplares similares